A detailed history of Ccla Investment Management LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Ccla Investment Management LTD holds 856,914 shares of ABT stock, worth $99 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares
856,914
Previous 856,914 -0.0%
Holding current value
$99 Million
Previous $89.6 Million -0.0%
% of portfolio
1.38%
Previous 1.38%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $6.56 Million - $7.32 Million
65,090 Added 8.22%
856,914 $89.6 Million
Q1 2024

May 10, 2024

BUY
$109.52 - $120.96 $668,838 - $738,702
6,107 Added 0.78%
791,824 $90 Million
Q4 2023

Feb 08, 2024

BUY
$90.19 - $110.4 $15.6 Million - $19.1 Million
173,439 Added 28.33%
785,717 $86.7 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $69,927 - $83,901
732 Added 0.12%
612,278 $59.2 Million
Q2 2023

Aug 01, 2023

BUY
$100.78 - $112.29 $63,692 - $70,967
632 Added 0.1%
611,546 $66.6 Million
Q1 2023

May 03, 2023

BUY
$96.86 - $114.01 $7.05 Million - $8.29 Million
72,753 Added 13.52%
610,914 $61.9 Million
Q4 2022

Feb 01, 2023

SELL
$95.06 - $111.52 $2.6 Million - $3.05 Million
-27,386 Reduced 4.84%
538,161 $59.1 Million
Q3 2022

Nov 09, 2022

SELL
$96.76 - $112.03 $1.27 Million - $1.48 Million
-13,168 Reduced 2.28%
565,547 $54.7 Million
Q1 2022

Apr 29, 2022

SELL
$114.02 - $139.04 $1.36 Million - $1.65 Million
-11,900 Reduced 2.01%
578,715 $68.5 Million
Q4 2021

Feb 08, 2022

SELL
$115.53 - $141.46 $5.02 Million - $6.15 Million
-43,457 Reduced 6.85%
590,615 $83.1 Million
Q3 2021

Oct 29, 2021

BUY
$116.66 - $129.06 $680,244 - $752,548
5,831 Added 0.93%
634,072 $74.9 Million
Q2 2021

Aug 09, 2021

BUY
$105.79 - $124.53 $66.5 Million - $78.2 Million
628,241 New
628,241 $72.8 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ccla Investment Management LTD Portfolio

Follow Ccla Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ccla Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ccla Investment Management LTD with notifications on news.